Epstein Becker Green served as lead regulatory counsel to a large private equity firm in connection with its acquisition of a significant equity stake in a leading independent provider of specialty pharmacy services. The target serves pharmaceutical manufacturers through its medication adherence programs, data analytics, customized manufacturer programs, and nationwide nursing coverage for in-home infusion services.
Results may vary depending on your particular facts and legal circumstances.